Park J Y, Lee K U, Kim C H, Kim H K, Hong S K, Park K S, Lee H K, Min H K
Department of Internal Medicine, College of Medicine, University of Ulsan, Seoul, South Korea.
Diabetes Res Clin Pract. 1997 Feb;35(1):49-56. doi: 10.1016/s0168-8227(96)01363-0.
To determine the prevalence of past and current obesity among patients with non-insulin-dependent diabetes mellitus (NIDDM) and to define the clinical characteristics of non-obese NIDDM patients in South Korea, we studied a cross-section of 749 NIDDM patients and a group of age- and sex-matched control subjects. Current height, weight and waist-to-hip ratio (WHR), the history of weight changes and the family history of diabetes were recorded. Obesity was defined as body mass index (BMI) > 25 kg/m2. The maximum lifetime BMI of diabetic patients was significantly higher than that of control subjects (P < 0.001). Compared with control subjects, current BMI was higher in diabetic women (P < 0.001) but not in diabetic men. In contrast, WHR of both diabetic men and women were significantly higher than those of controls (P < 0.05). BMI and WHR correlated significantly with fasting C-peptide levels and log-triglyceride levels in NIDDM patients. As a whole, 72% of the South Korean NIDDM patients had a history of past obesity as assessed by their maximum weight, while only 38% of them were currently obese. Compared with obese patients, non-obese patients were characterized by lower fasting serum C-peptide levels (P < 0.001), a higher percentage of insulin treatment (P < 0.05), lower maximum BMI (P < 0.001) and more pronounced weight loss from the time at their maximum weight (P < 0.001). In summary, increased upper body adiposity and a history of past obesity were associated with NIDDM in South Korea. Although most South Korean NIDDM patients were previously obese, many of them were currently not obese. Lower maximum BMI, lower serum C-peptide levels and a higher percentage of insulin treatment in non-obese NIDDM patients suggest that the capacity to increase insulin secretion in response to increasing weight gain is rather limited in these patients.
为了确定韩国非胰岛素依赖型糖尿病(NIDDM)患者过去及当前肥胖症的患病率,并明确非肥胖NIDDM患者的临床特征,我们对749例NIDDM患者以及一组年龄和性别匹配的对照受试者进行了横断面研究。记录了当前身高、体重和腰臀比(WHR)、体重变化史以及糖尿病家族史。肥胖定义为体重指数(BMI)>25kg/m²。糖尿病患者的最大终生BMI显著高于对照受试者(P<0.001)。与对照受试者相比,糖尿病女性的当前BMI较高(P<0.001),而糖尿病男性则不然。相反,糖尿病男性和女性的WHR均显著高于对照组(P<0.05)。NIDDM患者的BMI和WHR与空腹C肽水平和对数甘油三酯水平显著相关。总体而言,根据最大体重评估,72%的韩国NIDDM患者有过去肥胖史,而目前只有38%的患者肥胖。与肥胖患者相比,非肥胖患者的特征是空腹血清C肽水平较低(P<0.001)、胰岛素治疗比例较高(P<0.05)、最大BMI较低(P<0.001)以及自最大体重时起体重减轻更为明显(P<0.001)。总之,上身肥胖增加和过去肥胖史与韩国的NIDDM相关。尽管大多数韩国NIDDM患者以前肥胖,但他们中的许多人目前并不肥胖。非肥胖NIDDM患者较低的最大BMI、较低的血清C肽水平和较高的胰岛素治疗比例表明,这些患者对体重增加做出胰岛素分泌增加的能力相当有限。